Compare Bio Protocol (BIO) vs THORChain (RUNE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs THORChain — how do they compare? Bio Protocol trades at Rp433.55 (market cap Rp983,84M, Rp162,92M 24h volume), while THORChain trades at Rp7,432 (market cap Rp2,53T, Rp51,1M 24h volume). The key difference: THORChain is far larger — about 2571.6× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 338,2M / 354,2M RUNE (96%) for THORChain. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and THORChain for 47 Days on average.
| BIO | RUNE | |
|---|---|---|
Market Cap | Rp983,84M | Rp2,53T |
Volume (24h) | Rp162,92M | Rp51,1M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 338,2M / 354,2M RUNE (96%) |
Typical Hold Time | 18 Days | 47 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
THORChain (RUNE) is trading at Rp7,625 with a market cap of Rp2.57 trillion, showing neutral technical signals overall. The asset maintains 96% circulation with strong moving average support but faces resistance near Rp7,688. Recent on-chain activity shows moderate network usage with no major protocol upgrades reported in the past month.
Outlook remains cautiously neutral with opportunities in cross-chain liquidity growth, though risks include regulatory uncertainty and typical crypto volatility. The token's utility in decentralized exchange infrastructure provides fundamental support, but investors should monitor trading volume patterns and broader market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About THORChain
THORCHain is a decentralized liquidity protocol that allows users to easily exchange cryptocurrency assets across a range of networks without losing full custody of their assets in the process. With THORChain, users can simply swap one asset for another in a permissionless setting, without needing to rely on order books to source liquidity. The native utility token of the THORChain platform is RUNE.
Read more on RUNE →
